Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications

Maraj, I., Makaryus, J. N., Ashkar, A., McFarlane, S. I., & Makaryus, A. N. (2013). Hypertension Management in the High Cardiovascular Risk Population. International Journal of Hypertension, 2013(), 172-178. https://doi.org/10.1155/2013/382802
Aguilar, G., Belda, F. J., Ferrando, C., & Jover, J. L. (2011). Assessing the Left Ventricular Systolic Function at the Bedside: The Role of Transpulmonary Thermodilution-Derived Indices. Anesthesiology Research and Practice, 2011(), 197-200. https://doi.org/10.1155/2011/927421
Wang, Y. B., Hao, G. Z., Jiang, Y. F., Fu, X. H., Fan, W. Z., Miao, Q., Wang, Q., Li, H. X., & Gu, X. S. (2019). Effects of Levosimendan on Right Ventricular Function in Patients with Acute Decompensated Heart Failure. Acta Cardiologica Sinica, 35(6), 585-591. https://doi.org/10.6515/ACS.201911_35(6).20190327A
Ho, W. L., Lin, C. P., Wang, C. L., Hsu, L. A., Yu, K. H., Luo, S. F., Chen, L. Y., & Hsu, T. S. (2014). Improvement of Right Ventricular Function in Pulmonary Arterial Hypertension with Disease-Specific Therapy-A Clinical Observational Study. Acta Cardiologica Sinica, 30(3), 236-244. https://www.airitilibrary.com/Article/Detail?DocID=10116842-201405-201405270028-201405270028-236-244
Singh, P., Sethi, N., Kaur, N., & Kozman, H. (2015). Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?. Clinical Medicine Insights: Cardiology, 2015(S1), 105-109. https://doi.org/10.4137/CMC.S18755